company background image
82C

NIOX Group DB:82C Stock Report

Last Price

€0.40

Market Cap

€185.4m

7D

-9.5%

1Y

-24.2%

Updated

25 Jan, 2023

Data

Company Financials +

82C Stock Overview

NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide.

82C fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

NIOX Group Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NIOX Group
Historical stock prices
Current Share PriceUK£0.40
52 Week HighUK£0.53
52 Week LowUK£0.28
Beta1.28
1 Month Change12.29%
3 Month Change0.50%
1 Year Change-24.15%
3 Year Change27.62%
5 Year Change-63.12%
Change since IPO-88.74%

Recent News & Updates

Recent updates

Shareholder Returns

82CDE BiotechsDE Market
7D-9.5%2.0%-0.9%
1Y-24.2%14.1%-9.6%

Return vs Industry: 82C underperformed the German Biotechs industry which returned 13.9% over the past year.

Return vs Market: 82C underperformed the German Market which returned -8.7% over the past year.

Price Volatility

Is 82C's price volatile compared to industry and market?
82C volatility
82C Average Weekly Movement6.4%
Biotechs Industry Average Movement5.4%
Market Average Movement5.2%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.3%

Stable Share Price: 82C is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 82C's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006111n/ahttps://investors.niox.com

NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022.

NIOX Group Plc Fundamentals Summary

How do NIOX Group's earnings and revenue compare to its market cap?
82C fundamental statistics
Market Cap€185.44m
Earnings (TTM)€14.96m
Revenue (TTM)€32.65m

12.4x

P/E Ratio

5.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
82C income statement (TTM)
RevenueUK£28.80m
Cost of RevenueUK£8.70m
Gross ProfitUK£20.10m
Other ExpensesUK£6.90m
EarningsUK£13.20m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Mar 21, 2023

Earnings per share (EPS)0.031
Gross Margin69.79%
Net Profit Margin45.83%
Debt/Equity Ratio0%

How did 82C perform over the long term?

See historical performance and comparison